Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good W@G Paul
W@G2 05/23/12 for a 05/25/12 close
61.62 Kookiekook
W@G1 05/21/12 for a 05/23/12 close
60.22 Kookiekook
Thank you Ray
Thanks Paul
Good W@G Ray
W@G2 05/16/12 for a 05/18/12 close
63.01 rayrohn
62.76 Kookiekook
while I apprecaite what you are saying, we both know there has been no real change in the quoted bid/ask for months. So the small sale at the bid price is meaningless in my opinion.
W@G1 05/14/12 for a 05/16/12 close
63.76 Kookiekook
Give the win to Paul and call it good. I'll make him pay for it next week.
W@G2 05/09/12 for a 05/11/12 close
63.33 Kookiekook
I'm just posting my views of may be happening with the drug industry as a whole.
Lately the FDA seems to have issued a number of extensions, including NAVB, VVUS and others. This seems to me to be more than usual and believe the cause is partially due to the congressional investigation of the FDA resulting in personnel devoting time to answer congress rather than being allowed to review PDUFA's.
W@G1 05/07/12 for a 05/09/12 close
63.74 Kookiekook
Thank you Farooq
Thank you Ray
I would have looked at $9 or $10 puts depending on price and premium.
Before approval, this stock was potentially more volatile due to the anticipation of a price swing when the FDA action was announced. Once the announcement was made the potential for further upward movement in the stock price was reduced considerably.
I learned a hard lesson not to buy and hold out-of-the-money options through a binary event. Even if you are right, the reduced volatility after the event reduces the chance of profitability considerably.
On the otherhand, options bought and sold just before the event is something I have begun looking at closer. In addition, In the Money options can be profitable. PLX May $5.00 Calls would have been profitable.
W@G2 05/02/12 for a 05/04/12 close
67.09 Kookiekook
For what it is worth, ASHM in this case appears to mean Annual Share Holders Meeting. People should always avoid using initials etc unless no misunderstanding of their usage can be made or they previously defined them in their posts etc. In this instance ASHM is also the accrynom for Australian Society for HIV Medicine.
W@G1 04/30/12 for a 05/02/12 close
67.23 Kookiekook
66.50 rayrohn
good W@G Farooq
The 8-K is merely a filing with the SEC concerning and incorporating the PR concerning the anticipated CRL from the FDA.
As this news have been already released and the market reacted to it, I do not anticipate any price reaction to it.
OT: I use a similiar plan, but the stops are mental not issued as a trade order. In addition, I pay attention to the Bollinger (2,20) bands. I do not buy any stock that is trading above them but do buy some that are below them (but I pay attention to their trend when I do that).
If your methodology is providing you with a profit, do not disgard it. Instead look to see what those three stocks did and if they have something in common look to see if that commonality can be included in your method. IE Tweak it.
In addition, be careful when accepting others advice as to which stocks to buy etc. You do not have to worry about Sheff as he is completely transparent as are some others here, but often you see and hear people on i-Hub claiming to have made impossible trades (including buying a stock that has no trade volume).
If your method is earning you more than a couple of % profit overall you are doing better than a savings account, so don't worry about the few that get away.
Thank you Ray and Paul
W@G2 04/25/12 for a 04/27/12 close
63.53 Kookiekook
W@G1 04/23/12 for a 04/25/12 close
66.11 Kookiekook
Thank you Ray, Paul and Farooq
Good W@G Farooq
W@G2 04/18/12 for a 04/20/12 close
66.11 Kookiekook
64.80 rayrohn
I checked Nuvo Research and Galderma Laboratories website (the sNDA was submitted by Galderma) and neither indicate any action from the FDA on Pliagis.
W@G1 04/16/12 for a 04/18/12 close
66.96 Kookiekook
Sorry, as nice as it would be to see a forward split, I do not see it as a possibility.
They only have 33.4 million outstanding and a market cap that is close to the lower limit for listing on NASDAQ. While approval would, imo, substantially raise the stock price, maybe even above the magic $5.00/share that would entice more institutional investors. A forward split would hinder any price around $5.00/share.
Second, if I remember correctly thay only have 75million shares authorized so unless that number was increased by the shareholders a 5:1 forward split is not possible.
Third the reason for a forward split of stock is to hold the price down in a range where the aerage stock buyer can afford it. Any stock lower than $20.00 per share does not really have that problem, and even with FDA approval, a 10x raise in the stock price isn't going to happen.
Good W@G Farooq
As a previous poster wrote, it will require some time before the new regulations take affect. Usually laws passed by Congress do not take affect immeadiately. It is typical that they only go into affect July 1, or Jan 1.
Also in this case, new procedures have to written and approved not only by the FDA but with the GAO and others. With any Federal Agency that can be very time-consuming, even more so it the agency is against the change and drags it feet. They can show they are making progress by writing proposals that are flawed requiring complete re-writes etc, and use that to show thay are making steps to implementing the new laws but require more time.
I'm not saying this is the case with the FDA, but I do not look for implementation quickly.
Scifi is correct in his statement to a point.
As with any trade, there is a buyer and a seller. While the buyer is betting that the stock will be above $1.00 (not including any R/S, dividends etc), someone else is betting that the stock will not trade above $1.00 before the expiration date. If is does, he is obligated to sell his stock to the buyer of the options at $1.00/share regardless of the market price.
W@G2 04/11/12 for a 04/13/12 close
67.23 Kookiekook
To determine that you would have to factor in the odds of approval and several other items. The possibility of a Reverse Split has complicated pricing of this stock for anything longer than the PDUFA decision date.
Read carefully:
With approval, I see a 3:1 R/S and price after split of $2.45
Without approval, I see a 10:1 R/S and price after split of $1.60
W@G1 04/09/12 for a 04/11/12 close
67.23 Kookiekook
66.50 Farooq
65.00 rayrohn
I believe it will affect the price some shorterm (ie a week or less) Probably by about 10%.
Reverse splits and dilution are not necessarily bad. But I would rather see a reverse split of 10:1 with the company retiring some of the authorized shares. Particularly when they claim the reverse is needed to maintain a share price for listing on a major exchange.
The good thing is this might remove the big seller that is holding the share price down, so when the dust settles next week we might see some real gains in the share price leading to the FDA decision date.